Doxorubicin
OCTO_095
Phase 1 small_molecule terminated
Quick answer
Doxorubicin for Pancreatic Ductal Adenocarcinoma is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated